Indomo Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $25M

  • Investors
  • 11

Indomo General Information

Description

Developer of acne care therapeutics intended to offer device-enabled innovations for acne care. The company offers an acne drug paired with a novel intradermal self-injection device for the resolution of moderate to severe acne lesions, allowing patients to access intralesional acne injections whenever and wherever they need them.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Letterman Drive
  • Suite C3500
  • San Francisco, CA 94129
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • 1 Letterman Drive
  • Suite C3500
  • San Francisco, CA 94129
  • United States

Indomo Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Indomo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 27-May-2025 $25M Completed Pre-Clinical Trials
3. Early Stage VC (Series A1) 21-Aug-2023 Completed Stealth
2. Accelerator/Incubator 01-Jul-2023 $120K $760K Completed Stealth
1. Early Stage VC (Series A2) 11-Oct-2022 $640K $640K Completed Stealth
To view Indomo’s complete valuation and funding history, request access »

Indomo Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B-1
Series A-2 38,837,830 $0.000001 $0.02 $0.02 1x $0.02 7.76%
Series A-1 129,218,582 $0.000001 $0.08 $0.08 1x $0.08 25.81%
To view Indomo’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Indomo Patents

Indomo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026218024-A1 Systems and devices for controlled fluid injection Pending 11-Apr-2025
AU-2022349691-A1 Systems, devices and methods for dermal treatments Pending 24-Sep-2021
CA-3232828-A1 Systems, devices and methods for dermal treatments Pending 24-Sep-2021
EP-4404829-A1 Systems, devices and methods for dermal treatments Pending 24-Sep-2021
EP-4404829-A4 Systems, devices and methods for dermal treatments Pending 24-Sep-2021 A61B5/4839
To view Indomo’s complete patent history, request access »

Indomo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Indomo Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Foresite Capital Growth/Expansion Minority
Atomic14 Ventures Venture Capital Minority
Atomic (Private Equity) Venture Capital Minority
Evolution VC Partners Venture Capital Minority
FORM Life Ventures Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Indomo FAQs

  • When was Indomo founded?

    Indomo was founded in 2021.

  • Where is Indomo headquartered?

    Indomo is headquartered in San Francisco, CA.

  • What is the size of Indomo?

    Indomo has 7 total employees.

  • What industry is Indomo in?

    Indomo’s primary industry is Drug Delivery.

  • Is Indomo a private or public company?

    Indomo is a Private company.

  • What is the current valuation of Indomo?

    The current valuation of Indomo is .

  • What is Indomo’s current revenue?

    The current revenue for Indomo is .

  • How much funding has Indomo raised over time?

    Indomo has raised $42.2M.

  • Who are Indomo’s investors?

    Foresite Capital, Atomic14 Ventures, Atomic (Private Equity), Evolution VC Partners, and FORM Life Ventures are 5 of 11 investors who have invested in Indomo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process